Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abbvie Inc (ABBV)

84.34   0.03 (0.04%) 10-24 22:34
Open: 84.64 Pre. Close: 84.31
High: 85.15 Low: 83.94
Volume: 4,143,056 Market Cap: 148,846M
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Illinois and currently employs 30,000 full-time employees. The firm is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. The company offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 85.295 - 85.702 85.702 - 86.072
Low: 82.918 - 83.401 83.401 - 83.839
Close: 83.556 - 84.338 84.338 - 85.048

Technical analysis

as of: 2020-10-23 4:40:08 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 101.39     One year: 104.45
Support: Support1: 82.56    Support2: 68.69
Resistance: Resistance1: 86.81    Resistance2: 89.43
Pivot: 85.98
Moving Average: MA(5): 84.02     MA(20): 86.24
MA(100): 93.03     MA(250): 88.51
MACD: MACD(12,26): -1.50     Signal(9): -1.41
Stochastic oscillator: %K(14,3): 20.62     %D(3): 15.02
RSI: RSI(14): 39.43
52-week: High: 101.28  Low: 62.55  Change(%): 7.7
Average Vol(K): 3-Month: 725440  10-Days: 717940

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ABBV has closed above bottom band by 24.9%. Bollinger Bands are 8.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Oct 2020
AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth - Nasdaq

Wed, 21 Oct 2020
Are You Looking for a High-Growth Dividend Stock? AbbVie (ABBV) Could Be a Great Choice - Yahoo Finance

Tue, 20 Oct 2020
AbbVie: Stock Will Break $100 Once Management And Market Are On Same Page - Seeking Alpha

Tue, 20 Oct 2020
Were Hedge Funds Right About Crowding AbbVie Inc (ABBV)? - Yahoo Finance

Fri, 16 Oct 2020
AbbVie Inc. [ABBV] fell -3.74% so far this year. What now? - The DBT News

Tue, 13 Oct 2020
What do the Fundamentals Predict for AbbVie Inc (ABBV) Stock? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 1,760
Shares Float (M) 1,760
% Held by Insiders 0.11
% Held by Institutions 76.76
Shares Short (K) 13,280
Shares Short P. Month (K) 12,410

Stock Financials

EPS 4.520
EPS Est This Year 5.530
EPS Est Next Year 6.560
Book Value (p.s.) 8.340
Profit Margin 19.20
Operating Margin 37.55
Return on Assets (ttm) 8.2
Return on Equity (ttm) 225.6
Qtrly Rev. Growth 26.3
Gross Profit (p.s.) 14.676
Sales Per Share 20.585
EBITDA (p.s.) 9.506
Qtrly Earnings Growth
Operating Cash Flow (M) 14,730
Levered Free Cash Flow (M) 13,020

Stock Valuations

PE Ratio 18.66
PEG Ratio 1.28
Price to Book value 10.11
Price to Sales 4.10
Price to Cash Flow 10.08

Stock Dividends

Dividend 4.610
Forward Dividend 4.720
Dividend Yield 0.05
Dividend Pay Date 2020-11-15
Ex-Dividend Date 2020-10-13
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.